← Evidence map

ArticleReports (MDPI)2026

Sacubitril/Valsartan in Patients with HFrEF Undergoing Maintenance Hemodialysis, Evidence of Cardiac Reverse Remodeling During 12-Month Follow-Up: Case Series.

Sonila Mocka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Sacubitril/Valsartan in Patients with HFrEF Undergoing Maintenance Hemodialysis, Evidence of Cardiac Reverse Remodeling During 12-Month Follow-Up: Case Series. | OpenQuestion